Systematic Analysis of Fly Models with Multiple Drivers Reveals Different Effects of Ataxin-1 and Huntingtin in Neuron Subtype-Specific Expression

The fruit fly, Drosophila melanogaster, is a commonly used model organism for neurodegenerative diseases. Its major advantages include a short lifespan and its susceptibility to manipulation using sophisticated genetic techniques. Here, we report the systematic comparison of fly models of two polyglutamine (polyQ) diseases. We induced expression of the normal and mutant forms of full-length Ataxin-1 and Huntingtin exon 1 in cholinergic, dopaminergic, and motor neurons, and glial cells using cell type-specific drivers. We systematically analyzed their effects based on multiple phenotypes: eclosion rate, lifespan, motor performance, and circadian rhythms of spontaneous activity. This systematic assay system enabled us to quantitatively evaluate and compare the functional disabilities of different genotypes. The results suggest different effects of Ataxin-1 and Huntingtin on specific types of neural cells during development and in adulthood. In addition, we confirmed the therapeutic effects of LiCl and butyrate using representative models. These results support the usefulness of this assay system for screening candidate chemical compounds that modify the pathologies of polyQ diseases.

[1]  E. Wanker,et al.  A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases , 2013, Nature Communications.

[2]  Edward W Green,et al.  Choosing and using Drosophila models to characterize modifiers of Huntington's disease. , 2012, Biochemical Society transactions.

[3]  E. Wanker,et al.  Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease , 2011, PloS one.

[4]  Nancy M Bonini,et al.  Modeling human trinucleotide repeat diseases in Drosophila. , 2011, International review of neurobiology.

[5]  George R. Jackson,et al.  Neurodegenerative models in Drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis , 2010, Neurobiology of Disease.

[6]  Andreas S. Thum,et al.  The Role of Dopamine in Drosophila Larval Classical Olfactory Conditioning , 2009, PloS one.

[7]  Subhabrata Sanyal,et al.  Genomic mapping and expression patterns of C380, OK6 and D42 enhancer trap lines in the larval nervous system of Drosophila. , 2009, Gene expression patterns : GEP.

[8]  J. Marsh,et al.  Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons , 2009, Neurobiology of Disease.

[9]  N. Perrimon,et al.  Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington’s disease model , 2009, Disease Models & Mechanisms.

[10]  Ronald L. Davis,et al.  Frontiers in Neural Circuits Neural Circuits , 2022 .

[11]  G. Casadesus,et al.  Neuroprotection by c-Jun NH2-terminal kinase inhibitor SP600125 against potassium deprivation–induced apoptosis involves the Akt pathway and inhibition of cell cycle reentry , 2009, Neuroscience.

[12]  E. Wanker,et al.  Glial Cell Lineage Expression of Mutant Ataxin-1 and Huntingtin Induces Developmental and Late-Onset Neuronal Pathologies in Drosophila Models , 2009, Neuroscience Research.

[13]  S. Kato,et al.  RNA-Binding Protein Hoip Accelerates PolyQ-Induced Neurodegeneration in Drosophila , 2008, Bioscience, biotechnology, and biochemistry.

[14]  R. Artero,et al.  Genetic and Chemical Modifiers of a CUG Toxicity Model in Drosophila , 2008, PloS one.

[15]  P. Verstreken,et al.  Suppression of Neurodegeneration and Increased Neurotransmission Caused by Expanded Full-Length Huntingtin Accumulating in the Cytoplasm , 2008, Neuron.

[16]  C. Wegener,et al.  Neuroarchitecture of Aminergic Systems in the Larval Ventral Ganglion of Drosophila melanogaster , 2007, PLoS ONE.

[17]  G. Technau,et al.  The commonly used marker ELAV is transiently expressed in neuroblasts and glial cells in the Drosophila embryonic CNS , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[18]  A. Guo,et al.  Study of tauopathies by comparing Drosophila and human tau in Drosophila , 2007, Cell and Tissue Research.

[19]  H. Zoghbi,et al.  RORα-Mediated Purkinje Cell Development Determines Disease Severity in Adult SCA1 Mice , 2006, Cell.

[20]  Jeffrey C. Hall,et al.  Neurotoxic protein expression reveals connections between the circadian clock and mating behavior in Drosophila , 2006, Proceedings of the National Academy of Sciences.

[21]  M. Saitoe,et al.  Expression of human PQBP‐1 in Drosophila impairs long‐term memory and induces abnormal courtship , 2006, FEBS letters.

[22]  Claire H. Michel,et al.  Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway. , 2005, Human molecular genetics.

[23]  Ronald Wetzel,et al.  Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. , 2004, Molecular cell.

[24]  Michele P Calos,et al.  Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. , 2004, Genetics.

[25]  Ming-tao Li,et al.  SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson’s disease , 2004, Neuroscience Research.

[26]  A. Goldberg,et al.  Protein degradation and protection against misfolded or damaged proteins , 2003, Nature.

[27]  A. Chiang,et al.  Aging Specifically Impairs amnesiac-Dependent Memory in Drosophila , 2003, Neuron.

[28]  Florence Friggi-Grelin,et al.  Tissue‐specific developmental requirements of Drosophila tyrosine hydroxylase isoforms , 2003, Genesis.

[29]  Jay Hirsh,et al.  Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase. , 2003, Journal of neurobiology.

[30]  T. Tabata,et al.  Androgen-Dependent Neurodegeneration by Polyglutamine-Expanded Human Androgen Receptor in Drosophila , 2002, Neuron.

[31]  Miratul M. K. Muqit,et al.  Modelling neurodegenerative diseases in Drosophila: a fruitful approach? , 2002, Nature Reviews Neuroscience.

[32]  D. Housman,et al.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.

[33]  T. Kitamoto,et al.  Drosophila cholinergic neurons and processes visualized with Gal4/UAS-GFP. , 2001, Brain research. Gene expression patterns.

[34]  M Gribskov,et al.  A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. , 2001, Genome research.

[35]  H. Zoghbi,et al.  Identification of genes that modify ataxin-1-induced neurodegeneration , 2000, Nature.

[36]  Iris Salecker,et al.  Polyglutamine-Expanded Human Huntingtin Transgenes Induce Degeneration of Drosophila Photoreceptor Neurons , 1998, Neuron.

[37]  Nancy M Bonini,et al.  Expanded Polyglutamine Protein Forms Nuclear Inclusions and Causes Neural Degeneration in Drosophila , 1998, Cell.

[38]  Tim Tully,et al.  Associative Learning Disrupted by Impaired Gs Signaling in Drosophila Mushroom Bodies , 1996, Science.

[39]  T. Hosoya,et al.  Glial cells missing: A binary switch between neuronal and glial determination in drosophila , 1995, Cell.

[40]  C. Rickert,et al.  The homeobox gene repo is required for the differentiation and maintenance of glia function in the embryonic nervous system of Drosophila melanogaster. , 1995, Development.

[41]  Y. Jan,et al.  Distinct morphogenetic functions of similar small GTPases: Drosophila Drac1 is involved in axonal outgrowth and myoblast fusion. , 1994, Genes & development.

[42]  T. Préat,et al.  IDENTIFICATION OF LINOTTE, A NEW GENE AFFECTING LEARNING AND MEMORY IN DROSOPHILA MELANOGASTER , 2007, Journal of neurogenetics.